The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies
Abstract
Comprehensive genomic profiling enables genomic biomarker detection in advanced solid tumors. Here, to evaluate the utility of circulating tumor DNA (ctDNA) genotyping, we compare trial enrollment using ctDNA sequencing in 1,687 patients with advanced gastrointestinal (GI) cancer in SCRUM-Japan GOZILA (no. UMIN000016343), an observational ctDNA-based screening study, to enrollment using tumor tissue sequencing in the same centers and network (GI-SCREEN, 5,621 patients). ctDNA genotyping significantly shortened the screening duration (11 versus 33 days, P < 0.0001) and improved the trial enrollment rate (9.5 versus 4.1%, P < 0.0001) without compromising treatment efficacy compared to tissue genotyping. We also describe the clonal architecture of ctDNA profiles in ~2,000 patients with advanced GI cancer, which reinforces the relevance of many targetable oncogenic drivers and highlights multiple new drivers as candidates for clinical development. ctDNA genotyping has the potential to accelerate innovation in precision medicine and its delivery to individual patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This highlights the possible utility of liquid biopsies for molecular genotyping, facilitating more rapid patient access to targeted therapy options in the future (30).”
From Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRAS G12C-Mutated Metastatic Colorectal Cancer (2024) · cites this paper as [30]
Citations
Cites
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Chalmers, Z. R., Connelly, C. F., Fabrizio, D., Gay, L., Ali, S. M., Ennis, R., Schrock, A., Campbell, B., Shlien, A., Chmielecki, J., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0424-2 · Cited by 3,519
OncoKB: A Precision Oncology Knowledge Base
Chakravarty, D., Gao, J., Phillips, S. M., Kundra, R., Zhang, H., Wang, J., Rudolph, J. E., Yaeger, R. D., Soumerai, T. E., Nissan, M. H., et al. (2017) · JCO Precision Oncology · doi:10.1200/po.17.00011 · Cited by 2,783
Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer
Golan, T., Hammel, P., Reni, M., Van Cutsem, E., Macarulla, T., Hall, M. J., Park, J.-O., Hochhauser, D., Arnold, D., Oh, D.-Y., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1903387 · Cited by 2,302
Integrated genomic characterization of oesophageal carcinoma
Sun, Q., Kelsen, D. P., Wiznerowicz, M., Lu, Y., Sandusky, G., Wan, Y., Weinhold, N., Wong, A. M., Carvalho, A. L., Luketich, J. D., et al. (2017) · Nature · doi:10.1038/nature20805 · Cited by 1,869
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer
Kopetz, S., Grothey, A., Yaeger, R., Van Cutsem, E., Desai, J., Yoshino, T., Wasan, H., Ciardiello, F., Loupakis, F., Hong, Y. S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1908075 · Cited by 1,491
Self-citationBañales, J. M., Cardinale, V., Carpino, G., Marzioni, M., Andersen, J. B., Invernizzi, P., Lind, G. E., Folseraas, T., Forbes, S. J., Fouassier, L., et al. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.51 · Cited by 1,397
Abou‐Alfa, G. K., Macarulla, T. M., Javle, M. M., Kelley, R. K., Lubner, S. J., Adeva, J., Cleary, J. M., Catenacci, D. V. T., Borad, M. J., Bridgewater, J. A., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30157-1 · Cited by 1,159
Leighl, N. B., Page, R. D., Raymond, V. M., Daniel, D. B., Divers, S. G., Reckamp, K. L., Villalona-Calero, M. A., Dix, D., Odegaard, J. I., Lanman, R. B., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0624 · Cited by 593
Self-citationParikh, A. R., Leshchiner, I., Elagina, L., Goyal, L., Levovitz, C., Siravegna, G., Livitz, D., Rhrissorrakrai, K., Martin, E. E., Van Seventer, E. E., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0561-9 · Cited by 518
Research works printed but not linked: 1
- Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Preprint at https://arxiv.org/abs/1303.3997 (2013). · arXiv
Cited by
Sorted by citations
Liquid biopsy enters the clinic — implementation issues and future challenges
Ignatiadis, M., Sledge, G. W., & Jeffrey, S. S. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00457-x · Cited by 1,191
Pascual, J., Attard, G., Bidard, F.-C., Curigliano, G., De Mattos-Arruda, L., Diehn, M., Italiano, A., Lindberg, J., Merker, J. D., Montagut, C., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.05.520 · Cited by 783
Self-citationCancer biomarkers: Emerging trends and clinical implications for personalized treatment
Passaro, A., Bakir, M. A., Hamilton, E. G., Diehn, M., André, F., Roy‐Chowdhuri, S., Mountzios, G., Wistuba, I. I., Swanton, C., & Peters, S. (2024) · Cell · doi:10.1016/j.cell.2024.02.041 · Cited by 726
Current developments in gastric cancer: from molecular profiling to treatment strategy
Alsina, M., Arrazubi, V., Díez, M., & Tabernero, J. M. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00703-w · Cited by 368
Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices
Malla, M., Loree, J. M., Kasi, P. M., & Parikh, A. R. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02615 · Cited by 309
Nakamura, Y., Kawazoe, A., Lordick, F., Janjigian, Y. Y., & Shitara, K. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00492-2 · Cited by 307
Self-citationCirculating tumor DNA to monitor treatment response in solid tumors and advance precision oncology
Bartolomucci, A., de Nóbrega, M., Ferrier, S. T., Dickinson, K., Kaorey, N., Nadeau, A., Castillo, A., & Burnier, J. V. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00876-y · Cited by 301
Watanabe, J., Muro, K., Shitara, K., Yamazaki, K., Shiozawa, M., Ohori, H., Takashima, A., Yokota, M., Makiyama, A., Akazawa, N., et al. (2023) · JAMA · doi:10.1001/jama.2023.4428 · Cited by 280
Self-citationPrecision oncology in metastatic colorectal cancer — from biology to medicine
Nicolantonio, F. D., Vitiello, P. P., Marsoni, S., Siena, S., Tabernero, J. M., Trusolino, L., Bernards, R., & Bardelli, A. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00495-z · Cited by 244
Nakamura, Y., Okamoto, W., Kato, T., Esaki, T., Kato, K., Komatsu, Y., Yuki, S., Masuishi, T., Nishina, T., Ebi, H., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01553-w · Cited by 231
Self-citationThe coming decade in precision oncology: six riddles
Wahida, A., Buschhorn, L., Fröhling, S., Jost, P. J., Schneeweiß, A., Lichter, P., & Kurzrock, R. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00529-3 · Cited by 224
Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applications
He, G., Peng, X., Wei, S., Yang, S., Li, X., Huang, M., Tang, S., Jin, H., Liu, J., Zhang, S., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-021-01440-5 · Cited by 202
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
Jee, J., Lebow, E. S., Yeh, R., Das, J. P., Namakydoust, A., Paik, P. K., Chaft, J. E., Jayakumaran, G., Brannon, A. R., Benayed, R., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02047-z · Cited by 201
Mapping the genomic diaspora of gastric cancer
Yeoh, K. G., & Tan, P. B. O. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00412-7 · Cited by 175
Peng, Y., Mei, W., Ma, K., & Zeng, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.763790 · Cited by 167
Current and emerging therapies for advanced biliary tract cancers
Kam, A. E., Masood, A., & Shroff, R. T. (2021) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(21)00171-0 · Cited by 170
Taniguchi, H., Nakamura, Y., Kotani, D., Yukami, H., Mishima, S., Sawada, K., Shirasu, H., Ebi, H., Yamanaka, T., Aleshin, A. A., et al. (2021) · Cancer Science · doi:10.1111/cas.14926 · Cited by 166
Self-citationBerchuck, J. E., Facchinetti, F., Ditoro, D. F., Baiev, I., Majeed, U., Reyes, S., Chen, C. T., Zhang, K., Sharman, R., Usón, P. L. S., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.09.150 · Cited by 152
Yaeger, R., Uboha, N. V., Pelster, M. S., Bekaii-Saab, T. S., Barve, M., Saltzman, J., Sabari, J. K., Peguero, J. A., Paulson, A. S., Jänne, P. A., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0217 · Cited by 139
Practical considerations in screening for genetic alterations in cholangiocarcinoma
Bekaii‐Saab, T., Bridgewater, J. A., & Normanno, N. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.04.012 · Cited by 137
Recent developments in immunotherapy for gastrointestinal tract cancers
Chong, X., Madeti, Y., Cai, J., Li, W., Cong, L., Lu, J., Mo, L., Liu, H., He, S., Yu, C., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01578-x · Cited by 132
Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA
Chen, X., Zhao, D., Hubbell, E. A., Kurtzman, K. N., Oxnard, G. R., Venn, O., Melton, C. A., Clarke, C. A., Shaknovich, R., Ma, T., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0417 · Cited by 122
Shitara, K., Bang, Y., Iwasa, S., Sugimoto, N., Ryu, M., Sakai, D., Chung, H. C., Kawakami, H., Yabusaki, H., Sakamoto, Y., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02992-x · Cited by 126
Self-citationEffects of Metastatic Sites on Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer
Bando, H., Nakamura, Y., Taniguchi, H., Shiozawa, M., Yasui, H., Esaki, T., Kagawa, Y., Denda, T., Satoh, T., Yamazaki, K., et al. (2022) · JCO Precision Oncology · doi:10.1200/po.21.00535 · Cited by 111
Self-citationChida, K., Kawazoe, A., Kawazu, M., Suzuki, T., Nakamura, Y., Nakatsura, T., Kuwata, T., Ueno, T., Kuboki, Y., Kotani, D., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0401 · Cited by 110
Self-citationA clinician’s handbook for using ctDNA throughout the patient journey
Hasenleithner, S. O., & Speicher, M. R. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01551-7 · Cited by 110
Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation
Dao, J., Conway, P., Subramani, B., Meyyappan, D., Russell, S., & Mahadevan, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713219 · Cited by 112
Liquid biopsies to monitor and direct cancer treatment in colorectal cancer
Mauri, G., Vitiello, P. P., Sogari, A., Crisafulli, G., Bianchi, A. S., Marsoni, S., Siena, S., & Bardelli, A. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01769-8 · Cited by 108
Mechanisms of resistance to tyrosine kinase inhibitor‐targeted therapy and overcoming strategies
Ou, X., Gao, G., Habaz, I. A., & Wang, Y. (2024) · MedComm · doi:10.1002/mco2.694 · Cited by 104
Gastric cancer and genomics: review of literature
Onoyama, T., Ishikawa, S., & Isomoto, H. (2022) · Journal of Gastroenterology · doi:10.1007/s00535-022-01879-3 · Cited by 82
Wu, W., Liu, Y., Zeng, S., Han, Y., & Shen, H. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01166-3 · Cited by 83
Larribère, L., & Martens, U. M. (2021) · Cancers · doi:10.3390/cancers13225698 · Cited by 80
Clinical validation of Guardant360 CDx as a blood-based companion diagnostic for sotorasib
Bauml, J. M., Li, B. T., Velcheti, V., Govindan, R., Fontecedro, A. C., Dooms, C., Takahashi, T., Duda, A. W., Odegaard, J. I., Cruz‐Guilloty, F., et al. (2021) · Lung Cancer · doi:10.1016/j.lungcan.2021.10.007 · Cited by 73
Self-citationEarly stage gastric adenocarcinoma: clinical and molecular landscapes
Hirata, Y., Noorani, A., Song, S., Wang, L., & Ajani, J. A. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00767-w · Cited by 76
Sivapalan, L., Kocher, H. M., Ross‐Adams, H., & Chelala, C. (2020) · Pancreatology · doi:10.1016/j.pan.2020.12.017 · Cited by 73
Peppicelli, S., Calorini, L., Bianchini, F., Papucci, L., Magnelli, L., & Andreucci, E. (2024) · Cellular Oncology · doi:10.1007/s13402-024-00969-z · Cited by 72
How to use liquid biopsies to treat patients with cancer
Mattos‐Arruda, L. D., & Siravegna, G. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100060 · Cited by 70
Jogo, T., Nakamura, Y., Shitara, K., Bando, H., Yasui, H., Esaki, T., Terazawa, T., Satoh, T., Shinozaki, E., Nishina, T., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1414 · Cited by 65
Self-citationBayle, A., Peyraud, F., Belcaid, L., Brunet, M., Aldea, M. D., Clodion, R., Dubos, P., Vasseur, D., Nicotra, C., Géraud, A., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.08.089 · Cited by 65
Novel Biomarkers of Gastric Cancer: Current Research and Future Perspectives
Sato, Y., Okamoto, K., Kawano, Y., Kasai, A., Kawaguchi, T., Sagawa, T., Sogabe, M., Miyamoto, H., & Takayama, T. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144646 · Cited by 70
Targeted therapy guided by circulating tumor DNA analysis in advanced gastrointestinal tumors
Nakamura, Y., Ozaki, H., Ueno, M., Komatsu, Y., Yuki, S., Esaki, T., Taniguchi, H., Sunakawa, Y., Yamaguchi, K., Kato, K., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03244-8 · Cited by 66
Self-citationNakamura, Y., Fujisawa, T., Taniguchi, H., Bando, H., Okamoto, W., Tsuchihara, K., Yoshino, T., & Ohtsu, A. (2021) · Cancer Science · doi:10.1111/cas.15132 · Cited by 62
Self-citationCottrell, T. R., Lotze, M. T., Ali, A. M., Bifulco, C. B., Capitini, C. M., Chow, L. Q. M., Cillo, A. R., Collyar, D. E., Cope, L., Deutsch, J. S., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010928 · Cited by 65
Shimozaki, K., Hayashi, H., Tanishima, S., Horie, S., Chida, A., Tsugaru, K., Togasaki, K., Kawasaki, K., Aimono, E., Hirata, K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-99364-z · Cited by 57
The Emerging Role of Liquid Biopsy in Gastric Cancer
Lengyel, C. G., Hussain, S., Trapani, D., Bairi, K. E., Altuna, S. C., Seeber, A., Odhiambo, A. O., Habeeb, B. S., & Seid, F. U. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10102108 · Cited by 57
Current Status of the Diagnosis of Early-Stage Pancreatic Ductal Adenocarcinoma
Nakaoka, K., Ohno, E., Kawabe, N., Kuzuya, T., Funasaka, K., Nakagawa, Y., Nagasaka, M., Ishikawa, T., Watanabe, A., Tochio, T., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13020215 · Cited by 53
The Role of ctDNA in Gastric Cancer
Mencel, J., Slater, S., Cartwright, E., & Starling, N. (2022) · Cancers · doi:10.3390/cancers14205105 · Cited by 54
Lifestyles, genetics, and future perspectives on gastric cancer in east Asian populations
Katoh, H., & Ishikawa, S. (2021) · Journal of Human Genetics · doi:10.1038/s10038-021-00960-8 · Cited by 50
Fujii, Y., Ono, A., Hayes, C. N., Aikata, H., Yamauchi, M., Uchikawa, S., Kodama, K., Teraoka, Y., Fujino, H., Nakahara, T., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02016-3 · Cited by 49
Self-citationSoo, R. A., Martini, J.-F., van der Wekken, A. J., Teraoka, S., Ferrara, R., Shaw, A. T., Shepard, D., Calella, A. M., Polli, A., Toffalorio, F., et al. (2023) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2023.05.021 · Cited by 48
Clinical Utility and Benefits of Comprehensive Genomic Profiling in Cancer
Tjota, M. Y., Segal, J. P., & Wang, P. (2024) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfad091 · Cited by 49
Kwan, E. M., Ng, S. W. S., Tolmeijer, S. H., Emmett, L., Sandhu, S. K., Buteau, J. P., Iravani, A., Joshua, A. M., Francis, R. J., Subhash, V. V., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03704-9 · Cited by 49
Kitano, M., Minaga, K., Hatamaru, K., & Ashida, R. (2021) · Digestive Endoscopy · doi:10.1111/den.14120 · Cited by 46
Advances in Liquid Biopsy Technology and Implications for Pancreatic Cancer
Raufi, A. G., May, M. S., Hadfield, M. J., Seyhan, A. A., & El‐Deiry, W. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044238 · Cited by 47
Kobayashi, S., Nakamura, Y., Taniguchi, H., Odegaard, J. I., Nomura, S., Kojima, M., Sugimoto, M., Konishi, M., Gotohda, N., Takahashi, S., et al. (2021) · Annals of Surgical Oncology · doi:10.1245/s10434-020-09449-8 · Cited by 45
Self-citationRole of molecular genetics in the clinical management of cholangiocarcinoma
Normanno, N., Martinelli, E., Melisi, D., Pinto, C., Rimassa, L., Santini, D., & Scarpa, A. (2022) · ESMO Open · doi:10.1016/j.esmoop.2022.100505 · Cited by 45
Sunami, K., Naito, Y., Aimono, E., Amano, T., Ennishi, D., Kage, H., Kanai, M., Komine, K., Koyama, T., Maeda, T., et al. (2021) · International Journal of Clinical Oncology · doi:10.1007/s10147-020-01844-1 · Cited by 44
Self-citationComprehensive genomic profiling for oncological advancements by precision medicine
Pankiw, M., Brezden‐Masley, C., & Charames, G. S. (2023) · Medical Oncology · doi:10.1007/s12032-023-02228-x · Cited by 46
Yagisawa, M., Taniguchi, H., Satoh, T., Kadowaki, S., Sunakawa, Y., Nishina, T., Komatsu, Y., Esaki, T., Sakai, D., Doi, A., et al. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.23.02626 · Cited by 45
Self-citationProgress on diagnostic and prognostic markers of pancreatic cancer
YANG, H., Li, W., Ren, L., Yang, Y., Zhang, Y., Ge, B., Li, S., Zheng, X., Liu, J., Zhang, S., et al. (2023) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2023.028905 · Cited by 43
Chan, H. T., Chin, Y. M., & Low, S. (2022) · Cancers · doi:10.3390/cancers14133275 · Cited by 41
Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer
Patelli, G., Mauri, G., Tosi, F., Amatu, A., Bencardino, K. B., Bonazzina, E. F., Pizzutilo, E. G., Villa, F., Calvanese, G., Agostara, A. G., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0079 · Cited by 44
Körfer, J., Lordick, F., & Hacker, U. T. (2021) · Cancers · doi:10.3390/cancers13205216 · Cited by 42
Liquid biopsy versus tumor biopsy for clinical-trial recruitment
Corcoran, R. B. (2020) · Nature Medicine · doi:10.1038/s41591-020-01169-6 · Cited by 42
Duffy, M. J., & Crown, J. P. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12010099 · Cited by 40
Extracellular vesicle-cell adhesion molecules in tumours: biofunctions and clinical applications
Lin, W., Fang, J., Wei, S., He, G., Liu, J., Li, X., Peng, X., Dai, L., Yang, S., Li, X., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01236-8 · Cited by 41
Clinical implementation and current advancement of blood liquid biopsy in cancer
Watanabe, K., Nakamura, Y., & Low, S. (2021) · Journal of Human Genetics · doi:10.1038/s10038-021-00939-5 · Cited by 37
Self-citationHeidrich, I., Abdalla, T. S. A., Reeh, M., & Pantel, K. (2021) · Cancers · doi:10.3390/cancers13184500 · Cited by 38
Cell-free DNA testing for early hepatocellular carcinoma surveillance
Chen, L., Wu, T., Fan, R., Qian, Y.-S., Liu, J., Bai, J., Zheng, B. J., Liu, X., Zheng, D., Du, L., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2023.104962 · Cited by 37
Jiang, Q., Sun, J., Chen, H., Ding, C., Tang, Z., Ruan, Y., Liu, F., & Sun, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.650673 · Cited by 36
Genomic alterations in cholangiocarcinoma: clinical significance and relevance to therapy
Carotenuto, M., Sacco, A., Forgione, L., & Normanno, N. (2022) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2022.00079 · Cited by 36
Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer
Umemoto, K., Sunakawa, Y., Ueno, M., Furukawa, M., Mizuno, N., Sudo, K., Kawamoto, Y., Kajiwara, T., Ohtsubo, K., Okano, N., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02189-y · Cited by 35
Self-citationOhyama, H., Hirotsu, Y., Amemiya, K., Mikata, R., Amano, H., Hirose, S., Oyama, T., Iimuro, Y., Kojima, Y., Mochizuki, H., et al. (2023) · Cancer Genetics · doi:10.1016/j.cancergen.2023.12.002 · Cited by 34
Spencer, K. R., Pappas, L., Baiev, I., Maurer, J. R., Bocobo, A. G., Zhang, K., Jain, A., Armas, A. D. D., Reyes, S., Le, T. M., et al. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad046 · Cited by 33
Anti-EGFR Therapy in Metastatic Colorectal Cancer: Identifying, Tracking, and Overcoming Resistance
Leite, L. F., Noronha, M. M., de Menezes, J. S. A., da Conceição, L. D., Almeida, L. F. C., Cappellaro, A. P., Belotto, M., Biachi de Castria, T., Peixoto, R. D., & Megid, T. B. C. (2025) · Cancers · doi:10.3390/cancers17172804 · Cited by 32
Martín-Arana, J., Gimeno-Valiente, F., Henriksen, T. V., García-Micó, B., Martínez-Castedo, B., Gambardella, V., Martínez‐Ciarpaglini, C., Lucas, B. P.-D., Huerta, M., Camblor, D. G., et al. (2025) · Nature Cancer · doi:10.1038/s43018-025-00960-z · Cited by 36
Marshall, J. L., Peshkin, B. N., Yoshino, T., Vowinckel, J., Danielsen, H. E., Melino, G., Tsamardinos, I., Haudenschild, C. D., Kerr, D. J., Sampaio, C., et al. (2022) · The Oncologist · doi:10.1093/oncolo/oyab048 · Cited by 34
Self-citationCirculating Tumor DNA: A Pan-Cancer Biomarker in Solid Tumors with Prognostic and Predictive Value
Hitchen, N., Shahnam, A., & Tie, J. (2024) · Annual Review of Medicine · doi:10.1146/annurev-med-100223-090016 · Cited by 31
Applications of Liquid Biopsy for Surgical Patients With Cancer
Mahuron, K. M., & Fong, Y. (2023) · JAMA Surgery · doi:10.1001/jamasurg.2023.5394 · Cited by 31
Nakamura, Y., Okamoto, W., Denda, T., Nishina, T., Komatsu, Y., Yuki, S., Yasui, H., Esaki, T., Sunakawa, Y., Ueno, M., et al. (2022) · JCO Precision Oncology · doi:10.1200/po.21.00383 · Cited by 30
Self-citationMartín-Romano, P., Mezquita, L., Hollebecque, A., Lacroix, L., Rouleau, É., Gazzah, A., Bahleda, R., Planchard, D., Varga, A., Baldini, C., et al. (2022) · JCO Precision Oncology · doi:10.1200/po.21.00484 · Cited by 32
The biological function of tumor-derived extracellular vesicles on metabolism
Fu, X., Song, J., Yan, W., Downs, B. M., Wang, W., & Li, J. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01111-6 · Cited by 30
Targeted Therapies and Developing Precision Medicine in Gastric Cancer
Pihlak, R., Fong, C., & Starling, N. (2023) · Cancers · doi:10.3390/cancers15123248 · Cited by 29
Arimura, A., Sakai, K., Kaneshiro, K., Morisaki, T., Hayashi, S., Mizoguchi, K., Yamada, M., Kai, M., Ono, M., Nishio, K., et al. (2024) · Cancers · doi:10.3390/cancers16061184 · Cited by 28
Miyabayashi, K., Nakagawa, H., & Koike, K. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.682872 · Cited by 28
Vasseur, D., Sassi, H., Bayle, A., Tagliamento, M., Besse, B., Marzac, C., Arbab, A., Auger, N., Cotteret, S., Aldea, M. D., et al. (2022) · Cells · doi:10.3390/cells11121901 · Cited by 28
Potent molecular-targeted therapies for advanced esophageal squamous cell carcinoma
Ooki, A., Osumi, H., Chìn, K., Watanabe, M., & Yamaguchi, K. (2023) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359221138377 · Cited by 28
Self-citationCooperation and Interplay between EGFR Signalling and Extracellular Vesicle Biogenesis in Cancer
Zanetti-Domingues, L. C., Bonner, S. E., Iyer, R. S., Martin-Fernandez, M. L., & Huber, V. (2020) · Cells · doi:10.3390/cells9122639 · Cited by 29
Addressing Challenges in Targeted Therapy for Metastatic Colorectal Cancer
Hage, M. E., Su, Z., & Linnebacher, M. (2025) · Cancers · doi:10.3390/cancers17071098 · Cited by 27
Mishima, S., Nakamura, Y., Tukachinsky, H., Taniguchi, H., Kadowaki, S., Kato, K., Oki, E., Satoh, T., Aoki, D., Yamazaki, K., et al. (2023) · The Journal of Liquid Biopsy · doi:10.1016/j.jlb.2023.100003 · Cited by 30
Self-citationde Abreu, A. R., Wyninckx, A., Vandamme, T., de Beeck, K. O., Camp, G. V., Peeters, M., Laurent‐Puig, P., Taı̈eb, J., Taly, V., & Benhaïm, L. (2025) · The Oncologist · doi:10.1093/oncolo/oyaf204 · Cited by 29
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Sivapalan, L., Thorn, G. J., Gadaleta, E., Kocher, H. M., Ross‐Adams, H., & Chelala, C. (2022) · BMC Cancer · doi:10.1186/s12885-022-09387-6 · Cited by 26
Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor Boards
Crimini, E., Repetto, M., Tarantino, P., Ascione, L., Antonarelli, G., Guerini‐Rocco, E., Barberis, M. C. P., Mazzarella, L., & Curigliano, G. (2022) · Cancers · doi:10.3390/cancers14133193 · Cited by 26
Appropriate use of cancer comprehensive genome profiling assay using circulating tumor DNA
Sunami, K., Bando, H., Yatabe, Y., Naito, Y., Takahashi, H. E., Tsuchihara, K., Toyooka, S., Mimori, K., Kohsaka, S., Uetake, H., et al. (2021) · Cancer Science · doi:10.1111/cas.15022 · Cited by 24
Self-citationGreen, M. F., Bell, J. L., Hubbard, C. B., McCall, S. J., McKinney, M. S., Riedel, J., Menendez, C. S., Abbruzzese, J. L., Strickler, J. H., & Datto, M. (2021) · JCO Precision Oncology · doi:10.1200/po.21.00030 · Cited by 24
Clinical applications and perspectives of circulating tumor DNA in gastric cancer
Li, J. M., Zhang, D., Zhu, J., & Dong, L. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03209-4 · Cited by 24
Liquid biopsy for gastric cancer: Techniques, applications, and future directions
del Arco, C. D., Fernández‐Aceñero, M. J., & Medina, L. O. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i12.1680 · Cited by 24
Fujii, S., Kotani, D., Hattori, M., Nishihara, M., Shikanai, T., Hashimoto, J., Hama, Y., Nishino, T., Suzuki, M., Yoshidumi, A., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-4391 · Cited by 22
Self-citationAshida, R., & Kitano, M. (2022) · Digestive Endoscopy · doi:10.1111/den.14344 · Cited by 23
Essential updates 2020/2021: Advancing precision medicine for comprehensive rectal cancer treatment
Takemasa, I., Hamabe, A., Miyo, M., Akizuki, E., & Okuya, K. (2022) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12646 · Cited by 22
Metadata
- Authors
- Nakamura, Y., Taniguchi, H., Ikeda, M., Bando, H., Kato, K., Morizane, C., Esaki, T., Komatsu, Y., Kawamoto, Y., Takahashi, N., Ueno, M., Kagawa, Y., Nishina, T., Kato, T., Yamamoto, Y., Furuse, J., Denda, T., Kawakami, H., Oki, E., Nakajima, T., Nishida, N., Yamaguchi, K., Yasui, H., Goto, M., Matsuhashi, N., Ohtsubo, K., Yamazaki, K., Tsuji, A., Okamoto, W., Tsuchihara, K., Yamanaka, T., Miki, I., Sakamoto, Y., Ichiki, H., Hata, M., Yamashita, R., Ohtsu, A., Odegaard, J. I., & Yoshino, T.
- Affiliations
- National Cancer Center Hospital East (JP)
- Aichi Cancer Center (JP)
- National Cancer Center Hospital (JP)
- National Hospital Organization Kyushu Cancer Center (JP)
- Hokkaido University Hospital (JP)
- Saitama Cancer Center (JP)
- Kanagawa Cancer Center (JP)
- Kansai Rosai Hospital (JP)
- Shikoku Cancer Center (JP)
- Osaka National Hospital (JP)
- University of Tsukuba Hospital (JP)
- Kyorin University Hospital (JP)
- Chiba Cancer Center (JP)
- Kindai University Hospital (JP)
- Kyushu University (JP)
- St. Marianna University School of Medicine (JP)
- The University of Osaka (JP)
- The Cancer Institute Hospital (JP)
- Kobe Medical Center (JP)
- Osaka Medical and Pharmaceutical University Hospital (JP)
- Gifu University (JP)
- Kanazawa University (JP)
- Shizuoka Cancer Center (JP)
- Kagawa University Hospital (JP)
- Hiroshima University Hospital (JP)
- Guardant (United States) (US)
- Corresponding author
- Yoshino, Takayuki
- ORCID
- Nakamura, Yoshiaki
- Taniguchi, Hiroya
- Ikeda, Masafumi
- Bando, Hideaki
- Kato, Ken
- Morizane, Chigusa
- Esaki, Taito
- Komatsu, Yoshito
- Kawamoto, Yasuyuki
- Takahashi, Naoki
- Ueno, Makoto
- Kagawa, Yoshinori
- Nishina, Tomohiro
- Kato, Takeshi
- Yamamoto, Yoshiyuki
- Furuse, Junji
- Denda, Tadamichi
- Kawakami, Hisato
- Oki, Eiji
- Nakajima, Takako
- Nishida, Naohiro
- Yamaguchi, Kensei
- Yasui, Hisateru
- Goto, Masahiro
- Matsuhashi, Nobuhisa
- Ohtsubo, Koushiro
- Yamazaki, Kentaro
- Tsuji, Akihito
- Okamoto, Wataru
- Tsuchihara, Katsuya
- Yamanaka, Takeharu
- Sakamoto, Yasutoshi
- Ichiki, Hiroko
- Yamashita, Riu
- Ohtsu, Atsushi
- Odegaard, Justin I.
- Yoshino, Takayuki
- Venue
- Nature Medicine
- Published
- 2020-10-05
- Volume
- 26
- Issue
- 12
- Pages
- 1859-1864
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W3089353724
- Cited by
- 373
- References
- 32
- Citations by year
- 2026: 41 · 2025: 57 · 2024: 60 · 2023: 71 · 2022: 73 · 2021: 67 · 2020: 3
- FWCI
- 18.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- circulating tumor DNA, liquid biopsy, advanced gastrointestinal cancer, clinical trial recruitment, clonal architecture, oncogenic drivers, precision medicine
- MeSH terms
- Circulating Tumor DNA, Adult, DNA, Neoplasm, Gastrointestinal Neoplasms, Genotype, Humans, Japan, Male, Middle Aged, Mutation, Biomarkers, Tumor, Precision Medicine, High-Throughput Nucleotide Sequencing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
